Medivolve Inc. (MEDVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.36 Million CAD | -87.42% |
| 2022 | 18.81 Million CAD | -68.26% |
| 2021 | 59.29 Million CAD | 209.94% |
| 2020 | 19.13 Million CAD | 731.62% |
| 2019 | 2.3 Million CAD | -49.78% |
| 2018 | 4.58 Million CAD | -13.53% |
| 2017 | 5.29 Million CAD | 138.51% |
| 2016 | 2.22 Million CAD | 133.13% |
| 2015 | 952.78 Thousand CAD | -26.46% |
| 2014 | 1.29 Million CAD | -70.98% |
| 2013 | 4.46 Million CAD | -58.56% |
| 2012 | 10.77 Million CAD | -19.06% |
| 2011 | 13.3 Million CAD | 88.23% |
| 2010 | 7.07 Million CAD | -14.27% |
| 2009 | 8.24 Million CAD | 293.75% |
| 2008 | 2.09 Million CAD | 430.27% |
| 2007 | 395.01 Thousand CAD | 2297.38% |
| 2006 | 16.47 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.76 Million CAD | -25.5% |
| 2023 Q3 | 10.33 Million CAD | -23.26% |
| 2023 Q4 | 2.36 Million CAD | -77.1% |
| 2023 Q1 | 14.01 Million CAD | -25.52% |
| 2023 FY | 2.36 Million CAD | -87.42% |
| 2023 Q2 | 13.46 Million CAD | -3.91% |
| 2022 Q2 | 32.36 Million CAD | -34.73% |
| 2022 Q4 | 18.81 Million CAD | -26.53% |
| 2022 Q3 | 25.61 Million CAD | -20.85% |
| 2022 FY | 18.81 Million CAD | -68.26% |
| 2022 Q1 | 49.58 Million CAD | -16.38% |
| 2021 FY | 59.29 Million CAD | 209.94% |
| 2021 Q1 | 17.12 Million CAD | -10.5% |
| 2021 Q3 | 32.2 Million CAD | 171.9% |
| 2021 Q4 | 59.29 Million CAD | 84.14% |
| 2021 Q2 | 11.84 Million CAD | -30.84% |
| 2020 Q3 | 32.54 Million CAD | 22.46% |
| 2020 FY | 19.13 Million CAD | 731.62% |
| 2020 Q1 | 4.72 Million CAD | 105.27% |
| 2020 Q2 | 26.57 Million CAD | 462.75% |
| 2020 Q4 | 19.13 Million CAD | -41.21% |
| 2019 Q4 | 2.3 Million CAD | -11.39% |
| 2019 Q2 | 3.35 Million CAD | -19.04% |
| 2019 Q3 | 2.59 Million CAD | -22.59% |
| 2019 Q1 | 4.14 Million CAD | -9.58% |
| 2019 FY | 2.3 Million CAD | -49.78% |
| 2018 Q3 | 4.8 Million CAD | -4.15% |
| 2018 Q2 | 5.01 Million CAD | -3.41% |
| 2018 Q1 | 5.19 Million CAD | -2.02% |
| 2018 FY | 4.58 Million CAD | -13.53% |
| 2018 Q4 | 4.58 Million CAD | -4.68% |
| 2017 Q1 | 1.95 Million CAD | -12.0% |
| 2017 Q3 | 1.39 Million CAD | -11.09% |
| 2017 Q4 | 5.29 Million CAD | 280.8% |
| 2017 Q2 | 1.56 Million CAD | -19.95% |
| 2017 FY | 5.29 Million CAD | 138.51% |
| 2016 Q4 | 2.22 Million CAD | -10.89% |
| 2016 FY | 2.22 Million CAD | 133.13% |
| 2016 Q1 | 971.83 Thousand CAD | 2.0% |
| 2016 Q2 | 1.01 Million CAD | 4.75% |
| 2016 Q3 | 2.49 Million CAD | 144.88% |
| 2015 Q4 | 952.78 Thousand CAD | -14.67% |
| 2015 Q2 | 1.16 Million CAD | -0.66% |
| 2015 Q1 | 1.17 Million CAD | -9.45% |
| 2015 FY | 952.78 Thousand CAD | -26.46% |
| 2015 Q3 | 1.11 Million CAD | -4.18% |
| 2014 Q3 | 3.6 Million CAD | -6.01% |
| 2014 Q1 | 4 Million CAD | -10.19% |
| 2014 FY | 1.29 Million CAD | -70.98% |
| 2014 Q2 | 3.83 Million CAD | -4.27% |
| 2014 Q4 | 1.29 Million CAD | -64.09% |
| 2013 Q4 | 4.46 Million CAD | -11.58% |
| 2013 FY | 4.46 Million CAD | -58.56% |
| 2013 Q3 | 5.04 Million CAD | -7.05% |
| 2013 Q2 | 5.43 Million CAD | -10.43% |
| 2013 Q1 | 6.06 Million CAD | -43.7% |
| 2012 Q3 | 12.26 Million CAD | -1.48% |
| 2012 FY | 10.77 Million CAD | -19.06% |
| 2012 Q2 | 12.44 Million CAD | -3.31% |
| 2012 Q4 | 10.77 Million CAD | -12.15% |
| 2012 Q1 | 12.87 Million CAD | -3.28% |
| 2011 Q2 | 12.96 Million CAD | 84.82% |
| 2011 Q1 | 7.01 Million CAD | -0.75% |
| 2011 FY | 13.3 Million CAD | 88.23% |
| 2011 Q4 | 13.3 Million CAD | 1.49% |
| 2011 Q3 | 13.11 Million CAD | 1.11% |
| 2010 FY | 7.07 Million CAD | -14.27% |
| 2010 Q3 | 7.18 Million CAD | -3.53% |
| 2010 Q2 | 7.44 Million CAD | -6.31% |
| 2010 Q1 | 7.94 Million CAD | -3.65% |
| 2010 Q4 | 7.07 Million CAD | -1.56% |
| 2009 Q3 | 8.43 Million CAD | 217.26% |
| 2009 Q2 | 2.65 Million CAD | 33.47% |
| 2009 Q1 | 1.99 Million CAD | -4.94% |
| 2009 FY | 8.24 Million CAD | 293.75% |
| 2009 Q4 | 8.24 Million CAD | -2.18% |
| 2008 Q1 | 383.34 Thousand CAD | -2.95% |
| 2008 Q2 | 318.14 Thousand CAD | -17.01% |
| 2008 FY | 2.09 Million CAD | 430.27% |
| 2008 Q4 | 2.09 Million CAD | -3.36% |
| 2008 Q3 | 2.16 Million CAD | 581.26% |
| 2007 Q1 | 44.95 Thousand CAD | 172.83% |
| 2007 Q2 | 43.71 Thousand CAD | -2.76% |
| 2007 Q3 | 436.69 Thousand CAD | 898.95% |
| 2007 Q4 | 395.01 Thousand CAD | -9.54% |
| 2007 FY | 395.01 Thousand CAD | 2297.38% |
| 2006 FY | 16.47 Thousand CAD | 0.0% |
| 2006 Q4 | 16.47 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -86.501% |
| Arrayit Corporation | 1 Million USD | -136.578% |
| Atlantic International Corp. | 4.43 Million USD | 46.652% |
| Biocept, Inc. | 30.87 Million USD | 92.334% |
| Bioqual, Inc. | 56.58 Million USD | 95.818% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -920.429% |
| DermTech, Inc. | 121.93 Million USD | 98.059% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.943% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 86.687% |
| iMD Companies, Inc. | 190.13 Thousand USD | -1144.735% |
| IDenta Corp. | 1.52 Million USD | -54.76% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 81.824% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 71.319% |
| InVitro International | 1.53 Million USD | -54.282% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 91.182% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -102265.96% |
| Medical Imaging Corp. | 4.19 Million USD | 43.537% |
| NovelStem International Corp. | 2.25 Million USD | -4.975% |
| Optigenex Inc. | 1.88 Million USD | -25.336% |
| PharmChem, Inc. | 2.76 Million USD | 14.422% |
| Proteome Sciences plc | 14.58 Million USD | 83.774% |
| Response Genetics, Inc | 48.88 Million USD | 95.159% |
| Rennova Health, Inc. | 20.57 Million USD | 88.496% |
| RushNet, Inc. | 6.04 Million USD | 60.865% |
| ScreenPro Security Inc. | 1.26 Million USD | -87.631% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -400.971% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -237.786% |
| Todos Medical Ltd. | 15.26 Million USD | 84.498% |